FDA Inspection 1055655 — Refocus Group, Inc.
The FDA completed an inspection of Refocus Group, Inc. on May 24, 2018 in Irving, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2018
- Fiscal Year
- 2018
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Irving, TX (United States)
Additional Details
Sponsor, Contract Research Organization